6 completed. 6 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 4 | Completed 4 |
Follow Aplastic Anemia: new trials by email Literature Review of Aplastic Anemia trials Research Report on Aplastic Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia PF-06462700 - Aplastic Anemia | Phase 3 | Completed | Pfizer | 3 | 2020-07-25 | 2022-04-27 |
| Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia Romiplostim - Aplastic Anemia | Phase 2 / Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 24 | 2019-12-03 | 2022-05-26 |
| Study of AMG531(Romiplostim) in Patients With Aplastic Anemia Romiplostim - Aplastic Anemia | Phase 2 / Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 17 | 2019-04-25 | 2022-05-26 |
| Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Romiplostim - Aplastic Anemia | Phase 2 / Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 46 | 2016-05-01 | 2024-07-16 |
| Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA Campath 1H, Cyclophosphamide, Fludarabine - Dyskeratosis Congenita, Aplastic Anemia | Phase 2 / Phase 3 | Completed | Masonic Cancer Center, University of Minnesota | 36 | 2007-08-01 | 2017-12-05 |
| Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia Anti-thymocyte globulin, Cyclophosphamide, Bone marrow transplantation - Aplastic Anemia | Phase 3 | Completed | Roswell Park Cancer Institute | 224 | 1998-09-01 | 2018-03-12 |
Anemia, Aplastic (6) · Dyskeratosis Congenita (1) · Hematologic Diseases (1) · Rare Diseases (1)
Anemia (6) · Bone Marrow Diseases (6) · Bone Marrow Failure Disorders (6) · Hemic and Lymphatic Diseases (6) · Hematologic Diseases (5) · Congenital Abnormalities (1) · Congenital Bone Marrow Failure Syndromes (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Abnormalities (1) · Skin Diseases (1)
romiplostim (3) · Antilymphocyte Serum (2) · Bone Marrow Transplantation (2) · Cyclophosphamide (2) · Alemtuzumab (1) · Methylprednisolone (1) · Radiotherapy (1) · Stem Cell Transplantation (1) · Whole-Body Irradiation (1) · fludarabine (1) · fludarabine phosphate (1) · thymoglobulin (1)
Kyowa Kirin Co., Ltd. (3) · Masonic Cancer Center, University of Minnesota (1) · Pfizer (1) · Roswell Park Cancer Institute (1)
Japan (4) · United States (2) · South Korea (1)